Oxygen Concentrators Market Size & Growth Forecast 2027–2036, By Segments (Product, Technology, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Oxygen Concentrators Market size was estimated at USD 5.2 billion in 2026 and is projected to grow at a 3.99% CAGR from 2027 to 2036, reaching USD 7.69 billion by 2036. The industry revenue for 2027 is assessed at USD 5.37 billion.

• Base Year Value (2026): USD 5.2 billion
• CAGR (2027-2036): 3.99%
• Forecast Year Value (2036): USD 7.69 billion
• Historical Data Period: 2022-2026
• Largest Region: North America
• Forecast Period: 2027-2036

Oxygen Concentrators Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America accounted for 43.46% of the market in 2026, supported by established home healthcare systems, broad diagnosis of respiratory diseases, and efficient distribution across hospitals and homecare providers.
  • Asia Pacific is projected to grow at a 6.1% CAGR due to expanding healthcare infrastructure, rising access to respiratory care, and wider adoption of home-based oxygen therapy.

• Segment Momentum:

  • Fixed Oxygen Concentrators accounted for 56.81% of the market in 2026 due to strong demand for continuous, long-duration oxygen therapy in home settings where reliability and higher output are priorities.
  • Portable Oxygen Concentrators are growing rapidly as patients increasingly seek mobility, convenience, and greater independence while maintaining ongoing oxygen therapy during daily activities and travel.

• Market Expansion Drivers:

  • Rising prevalence of chronic respiratory diseases increasing long-term oxygen therapy demand.
  • Expanding home healthcare adoption driving portable oxygen concentrator deployment.
  • Improved reimbursement policies expanding patient access to oxygen therapy devices.

• Leading Market Participants:

  Key players in the oxygen concentrators market include Inogen, Inc. (United States), Koninklijke Philips N.V. (Netherlands), Niterra Co., Ltd. (Japan), Drive DeVilbiss Healthcare (United States), Teijin Limited (Japan), React Health Holdings, LLC (United States), GF Health Products, Inc. (United States), O2 Concepts, LLC (United States), GCE Group (Sweden), BPL Medical Technologies Private Limited (India).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2026 Market Size: USD 5.2 billion
  • 2027 Estimated Market Size: USD 5.37 billion.
  • Projected Market Size: USD 7.69 billion by 2036
  • Growth Forecasts: 3.99% CAGR (2027-2036)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Fixed Oxygen Concentrators (Product) | Continuous Flow (Technology) | Home Care (Application)
  • Emerging Opportunity Segment: Portable Oxygen Concentrators (Product) | Pulse Flow (Technology) | Home Care (Application)

Market Growth Drivers and Industry Trends

Rising prevalence of chronic respiratory diseases increasing long-term oxygen therapy demand

The growing prevalence of chronic respiratory conditions is increasing the number of patients who require supplemental oxygen as part of long-term disease management. This trend will drive the oxygen concentrators market growth as concentrators provide a means of delivering oxygen-enriched air for patients requiring ongoing oxygen therapy. The increasing need for respiratory support across healthcare facilities and home-care environments is expanding demand for devices that can provide consistent oxygen delivery without relying on conventional compressed oxygen cylinders. Growing attention to chronic respiratory disease management is also strengthening the role of oxygen therapy within longer-term patient care pathways.

Expanding home healthcare adoption driving portable oxygen concentrator deployment

The shift toward home-based healthcare is encouraging greater use of medical devices that allow patients to receive respiratory support outside traditional hospital environments. Expanding home-care models will propel the oxygen concentrators market growth by increasing demand for portable systems that can support oxygen therapy while providing greater mobility and convenience for eligible patients. Portable concentrators can reduce dependence on frequent cylinder replacement and enable oxygen delivery within residential settings and during selected daily activities. The broader development of home healthcare infrastructure, remote patient support, and decentralized care models is further creating favorable conditions for wider deployment of portable respiratory equipment.

Improved reimbursement policies expanding patient access to oxygen therapy devices

Improvements in reimbursement frameworks can reduce financial barriers associated with long-term oxygen therapy and make respiratory support devices more accessible to eligible patients. More favorable coverage will boost the oxygen concentrators market demand by enabling healthcare providers and patients to consider oxygen concentrators as part of ongoing treatment and home-care arrangements. Reimbursement support can also improve continuity of therapy by reducing the direct financial burden associated with obtaining and maintaining required equipment. As healthcare systems place greater emphasis on accessible chronic disease management, reimbursement mechanisms are becoming an important factor influencing the adoption of home-based oxygen therapy devices.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Rising prevalence of chronic respiratory diseases increasing long-term oxygen therapy demand	2.10%	High	North America, Europe	High	Near Term
Expanding home healthcare adoption driving portable oxygen concentrator deployment	1.80%	Moderate	North America, Asia Pacific	High	Near Term
Improved reimbursement policies expanding patient access to oxygen therapy devices	1.60%	High	North America, Europe	High	Near Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America led the oxygen concentrators market with a 43.46% share in 2026, underpinned by well-developed healthcare systems, strong access to respiratory care, and growing demand for home-based medical treatment. The region benefits from established healthcare delivery networks and increasing preference for portable and home-use oxygen therapy that can support patient mobility and reduce dependence on hospital-based care. Technological improvements in concentrator portability, energy efficiency, monitoring, and ease of operation are further encouraging adoption, while an aging population and increasing attention to chronic respiratory disease management sustain demand for reliable oxygen delivery equipment.

Asia Pacific represents the fastest-growing regional market, supported by expanding healthcare infrastructure, improving access to respiratory care, and rising awareness of home-based oxygen therapy. Growing healthcare investment and the development of medical device distribution networks are improving availability across both urban and underserved areas. Demand is also being strengthened by the increasing need for long-term respiratory support and greater acceptance of portable medical equipment outside traditional hospital settings. Local manufacturing capabilities and efforts to improve healthcare accessibility are contributing to broader adoption of oxygen concentrators across the region.

Key Country Insights

United States

Home Respiratory Care

The U.S. maintains strong demand for oxygen concentrators supporting home-based respiratory therapy and long-term patient management. Healthcare providers across the U.S. increasingly favor portable and connected devices that improve patient mobility while enabling remote monitoring capabilities.

Japan

Aging Care Solutions

Japan is strengthening adoption of oxygen concentrators to support an expanding elderly population requiring chronic respiratory care. Healthcare providers in Japan increasingly prioritize compact, quiet, and dependable devices suited for long-term home treatment.

South Korea

Connected Respiratory Devices

South Korea is incorporating oxygen concentrators into digitally enabled healthcare services that support remote patient management. Medical providers in South Korea are adopting advanced portable systems designed to improve treatment continuity and patient convenience.

Germany

Clinical Equipment Modernization

Germany continues to invest in oxygen concentrators for hospitals, rehabilitation centers, and home healthcare settings. Demand in Germany reflects interest in reliable, energy-efficient systems that meet stringent medical device quality and performance expectations.

France

Home Healthcare Expansion

France continues to expand oxygen concentrator utilization within home healthcare programs for chronic respiratory conditions. Healthcare providers in France are emphasizing patient comfort, device reliability, and efficient service support to improve long-term treatment outcomes.

Italy

Community Care Support

Italy is increasing deployment of oxygen concentrators across community healthcare and home treatment settings. Demand in Italy is influenced by efforts to improve accessibility for respiratory care while encouraging dependable equipment with simplified maintenance requirements.

Segment Leadership and Growth Trends

 

Product Segment Analysis: Fixed Oxygen Concentrators (Largest Segment) vs Portable Oxygen Concentrators (Fastest-Growing Segment)

Fixed oxygen concentrators accounted for the largest share of the oxygen concentrators market, representing 56.81% share in 2026, supported by their established use in long-term oxygen therapy across hospitals, clinics, and homecare environments. These systems provide a consistent oxygen supply and are particularly suitable for patients requiring extended respiratory support, making them an important component of chronic respiratory disease management. Growing demand for home-based healthcare, increasing prevalence of respiratory conditions, and the need for dependable oxygen delivery are reinforcing adoption of fixed systems. Their operational reliability and suitability for continuous use further strengthen their position among healthcare providers and patients requiring stable oxygen therapy.

Portable oxygen concentrators are the fastest-growing product segment, driven by increasing demand for mobility, convenience, and greater independence among patients receiving supplemental oxygen. Their compact design and battery-operated functionality make them suitable for travel, outdoor activities, and routine daily use, aligning with the broader shift toward patient-centered and home-based care. Ongoing improvements in device portability, battery efficiency, oxygen delivery mechanisms, and ease of operation are expanding their practical applications. As patients increasingly seek respiratory support without being restricted to stationary treatment settings, portable systems are gaining traction across both homecare and ambulatory applications.

Technology Segment Analysis: Continuous Flow (Largest Segment) vs Pulse Flow (Fastest-Growing Segment)

Continuous flow technology held the largest share of the oxygen concentrators market, accounting for 57.65% share in 2026, owing to its ability to provide a steady oxygen supply regardless of the patient's breathing pattern. This characteristic makes continuous flow systems particularly valuable for patients requiring dependable oxygen delivery over prolonged periods, including during rest and sleep. Their established clinical use, consistent performance, and suitability for a broad range of oxygen therapy requirements continue to support adoption. In addition, the expansion of home respiratory care is sustaining demand for technologies capable of providing reliable and uninterrupted oxygen support.

Pulse flow technology is experiencing the fastest growth as healthcare delivery increasingly emphasizes portability, oxygen efficiency, and patient mobility. These systems deliver oxygen in response to inhalation, enabling more efficient utilization of the available oxygen supply while supporting compact device designs. This makes pulse flow particularly attractive for ambulatory patients who want greater freedom of movement during daily activities. Advancements in breath-detection capabilities, sensor technologies, and portable concentrator design are further improving usability and reliability, encouraging wider adoption of pulse flow systems across homecare and mobile oxygen therapy applications.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
Product	Portable Oxygen Concentrators, Fixed Oxygen Concentrators	Fixed Oxygen Concentrators	Portable Oxygen Concentrators
Technology	Continuous Flow, Pulse Flow	Continuous Flow	Pulse Flow
Application	Home Care, Non- Home Care	Home Care	Home Care

Competitive Landscape and Market Positioning

Top players in the oxygen concentrators market:

1. Inogen Inc. (United States)

2. Koninklijke Philips N.V. (Netherlands)

3. Niterra Co. Ltd. (Japan)

4. Drive DeVilbiss Healthcare (United States)

5. Teijin Limited (Japan)

6. React Health Holdings LLC (United States)

7. GF Health Products Inc. (United States)

8. O2 Concepts LLC (United States)

9. GCE Group (Sweden)

10. BPL Medical Technologies Private Limited (India)

Rising demand for home-based respiratory care is encouraging innovation across the oxygen concentrators market. Product development is focused on portable designs, smart monitoring capabilities, and energy-efficient systems that improve patient mobility, treatment convenience, and long-term oxygen therapy management.

Industry Development/News

Company Name	Date	Key Development
Unitaid	Mar-25	Unitaid expanded its regional oxygen production network into Tanzania via the East African Program on Oxygen Access. By coordinating investment with regional partners like TOL Gases Plc, the initiative targets a tripling of regional production capacity and a 25% price reduction, strengthening supply chain resilience and local medical oxygen self-sufficiency.
Oxymed	Apr-24	Oxymed launched the 5 LPM “Cure” oxygen concentrator in India, targeting the affordable home healthcare segment. The device features integrated purity monitoring and improved energy efficiency. By positioning the product at a competitive price point supported by a national service network, Oxymed aims to increase market penetration in the domestic home oxygen therapy space.
Inogen	Apr-24	Inogen introduced the Voxi 5 stationary oxygen concentrator, marking a strategic expansion of its portfolio beyond portable devices. This move allows the company to address the long-term care needs of residential and home-based patients, leveraging its existing distribution infrastructure to capture greater share in the stationary oxygen therapy market.
Inogen	Feb-24	Inogen launched the Rove 4 portable oxygen concentrator, featuring enhanced flow settings capable of delivering 840 ml/min. This product development reinforces the company’s focus on high-performance, mobility-oriented respiratory solutions, addressing the demand for continuous oxygen therapy among active patient populations.
Unitaid	Mar-24	Unitaid, in collaboration with MedAccess and Synergy Gases Ltd, launched a financing and manufacturing initiative to scale oxygen access across sub-Saharan Africa. The program focuses on establishing regional production networks and improving supply reliability in underserved healthcare systems, representing a major strategic investment in critical respiratory infrastructure.